Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1

Overview of attention for article published in Oncotarget, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 2 news outlets

blogs: 1 blog

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 33 Mendeley

Summary News Blogs Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies

Article in International Journal of Nanomedicine (August 2024)

Monovalent Pseudo-Natural Product Degraders Supercharge the Native Degradation of IDO1 by KLHDC3

Preprint in bioRxiv (July 2024)

Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype

Article in Frontiers in Immunology (March 2024)